Comprehensive Genomic Profiling of 724 Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs).

Journal of Clinical Oncology - United States
doi 10.1200/jco.2018.36.15_suppl.4098
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Circulating Markers in Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs)

2012English

Current Treatment Strategies for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Clinical Diabetes and Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Comprehensive Genomic Profiling Identifies Novel NTRK Fusions in Neuroendocrine Tumors

Oncotarget
Oncology
2018English

Risk Factors Associated With Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in a Cohort of 2.3 Million Israeli Adolescents

International Journal of Cancer
Cancer ResearchOncology
2018English

MicroRNA Analysis of Gastroenteropancreatic Neuroendocrine Tumors and Metastases

Oncotarget
Oncology
2018English

Resistance to Targeted Treatment of Gastroenteropancreatic Neuroendocrine Tumors

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2019English

Neuroendocrine Neoplasms: A Brief Overview Emphasizing Gastroenteropancreatic Tumors

Autopsy and Case Reports
2017English

Identification of Primary Tumors in Patients Presenting With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Surgery
Surgery
2017English

Catecholamine Production in Patients With Gastroenteropancreatic Neuroendocrine Tumors

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy